GlaxoSmithKline's mishandling of information on safety problems with diabetes drug Avandia is just one of the violations cited in a settlement with the government. Joe Raedle/Getty Images hide caption

toggle caption
Joe Raedle/Getty Images
Anel Fernandez/Cover/Getty Images

NPR's Carrie Johnson, on the inspector general's report

  • <iframe src="" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">